Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II

Rationale: The Scleroderma Lung Study II (SLS II) demonstrated significant improvements in pulmonary function and dyspnea at 24 months compared with baseline when patients with symptomatic scleroderma–related interstitial lung disease (SSc-ILD) were treated with either cyclophosphamide for 1 year (f...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Am Thorac Soc
Autori principali: Goldin, Jonathan G., Kim, Grace Hyun J., Tseng, Chi-Hong, Volkmann, Elizabeth, Furst, Daniel, Clements, Philip, Brown, Matt, Roth, Michael, Khanna, Dinesh, Tashkin, Donald P.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Thoracic Society 2018
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6322015/
https://ncbi.nlm.nih.gov/pubmed/30265153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201802-079OC
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi